← Eichor
Condition: Parkinson S Disease Dementia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Parkinson S Disease Dementia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06629207Parkinson's Disease and Movement Disorders Clinical Database
Phase N/A · 1 location(s) · University of Pennsylvania · NCT04997642Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Phase N/A · 1 location(s) · Douglas Scharre · NCT03019757Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
Phase N/A · 2 location(s) · Tianjin Medical University · NCT07685873Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT07720765Saliva and Extracellular Vesicles for Neurodegenerative Diseases
Phase N/A · 5 location(s) · Fondazione Don Carlo Gnocchi ETS · NCT06869135The Effects of Specific tDCS on Cognition in MCI
NA · 1 location(s) · Istanbul Medipol University Hospital · NCT05919485Impact of a Biophoton Therapy on Patients With Brain Disorders
NA · 1 location(s) · First Institute of All Medicines · NCT06147999Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Phase 1/Phase 2 · 3 location(s) · Ashvattha Therapeutics, Inc. · NCT05395624Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease
Phase 2 · 1 location(s) · The University of Queensland · NCT04643327Quantification of Hsp90 in the Human Brain
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07380204Retinal Imaging in Neurodegenerative Disease
Phase N/A · 1 location(s) · Duke University · NCT03233646Modifiable Variables in Parkinsonism (MVP)
Phase N/A · 1 location(s) · Bastyr University · NCT02194816PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Phase 1 · 1 location(s) · National Institute of Mental Health (NIMH) · NCT04396873Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease
NA · 3 location(s) · University Hospital, Montpellier · NCT06688968Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Dise
NA · 2 location(s) · Sanmai Technologies PBC dba Sanmai · NCT07207122The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Phase N/A · 38 location(s) · Russian Federation of Anesthesiologists and Reanimatologists · NCT03945968Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
NA · 1 location(s) · University Hospital, Bonn · NCT07324330Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypi
Phase N/A · 3 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06846658Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125Telehealth in Lewy Body Dementia
NA · 1 location(s) · University of Florida · NCT05014971Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrati
Phase N/A · 4 location(s) · University Health Network, Toronto · NCT06529744PET Imaging Evaluation of [11C]SY08
EARLY_Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT06098612Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Phase N/A · 1 location(s) · Hadassah Medical Organization · NCT00874783DRIVing Simulator and People With NeuroCognitive Disorders
Phase N/A · 1 location(s) · University Gustave Eiffel · NCT06320639Comparing Antipsychotic Medications in LBD Over Time
Phase 4 · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT05590637[18F]ACI-15916 PET in α-synucleinopathies
EARLY_Phase 1 · 1 location(s) · AC Immune SA · NCT06891703Comprehensive Assessment of Neurodegeneration and Dementia
Phase N/A · 19 location(s) · McGill University · NCT03402919NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106Autoimmune Features of Neurodegenerative Disorders
Phase N/A · 1 location(s) · Columbia University · NCT04239079
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.